Movement Disorders · 2011 · 140 citations · 20 references
Future trials assessing the clinical efficacy of chelating therapy should consider early symptomatic patients and a longer treatment period.
20
The MOS 36-ltem Short-Form Health Survey (SF-36)
John E. Ware, Cathy D. Sherbourne · Medical Care · 1992 · 29.1K citations
The Italian SF-36 Health Survey
Giovanni Apolone, Paola Mosconi · Journal of Clinical Epidemiology · 1998 · 1.1K citations
Validity and reliability of a rating scale for the primary torsion dystonias
Robert E. Burke, Stanley Fahn, C. D. Marsden et al. · Neurology · 1985 · 1.1K citations